183 related articles for article (PubMed ID: 22408877)
1. [Personalized medicine in oncology: from hope to reality].
Besse B; Soria JC
Rev Prat; 2012 Feb; 62(2):245-6. PubMed ID: 22408877
[No Abstract] [Full Text] [Related]
2. Oncology trials gear up for high-throughput sequencing.
Mullard A
Nat Rev Drug Discov; 2012 Apr; 11(5):339-40. PubMed ID: 22543457
[No Abstract] [Full Text] [Related]
3. [Biological network modelling and precision medicine in oncology].
Calzone L; Kuperstein I; Cohen D; Grieco L; Bonnet E; Servant N; Hupé P; Zinovyev A; Barillot E
Bull Cancer; 2014 Jun; 101 Suppl 1():S18-21. PubMed ID: 24966078
[TBL] [Abstract][Full Text] [Related]
4. Personalized cancer medicine.
Marmé D; Hallek M
Onkologie; 2012; 35 Suppl 1():2. PubMed ID: 22286580
[No Abstract] [Full Text] [Related]
5. Personalized medicine and therapeutic decision-making in oncology: a commentary on key environmental issues.
Freeman RA
J Oncol Pharm Pract; 2011 Sep; 17(3):295-7. PubMed ID: 20551112
[No Abstract] [Full Text] [Related]
6. It is fascinating to see how nowadays more and more knowledge of the molecular biological characteristics of the tumour lead to individualisation with surgery, radiotherapy and systemic treatment for patients with a malignancy. Introduction.
Bartelink H
Eur J Cancer; 2011 Sep; 47 Suppl 3():xxxv. PubMed ID: 21944037
[No Abstract] [Full Text] [Related]
7. [Clinical trials and personalized medicine in oncology?].
Arnold D; Bokemeyer C
Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
[TBL] [Abstract][Full Text] [Related]
8. Biomarkers and oncology: the path forward to a learning health system.
Yu PP; Hoffman MA; Hayes DF
Arch Pathol Lab Med; 2015 Apr; 139(4):451-6. PubMed ID: 25152310
[No Abstract] [Full Text] [Related]
9. Translational medicine promising personalized therapy in oncology.
Zeng YX; Zhang XS; Liu Q
Front Med China; 2010 Dec; 4(4):351-5. PubMed ID: 21107749
[No Abstract] [Full Text] [Related]
10. [Clinical research and human and social sciences at Institut National du Cancer (INCa)].
Amsellem N
Med Sci (Paris); 2012 Mar; 28 Spec No 1():6. PubMed ID: 22494649
[No Abstract] [Full Text] [Related]
11. Systems medicine: a real approach for future personalized oncology?
Roukos DH
Pharmacogenomics; 2010 Mar; 11(3):283-7. PubMed ID: 20235782
[No Abstract] [Full Text] [Related]
12. Personalized medicine in oncology: tailoring the right drug to the right patient.
Jiang Y; Wang M
Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
[TBL] [Abstract][Full Text] [Related]
13. [Desperately seeking targets].
Jordan B
Med Sci (Paris); 2015 Feb; 31(2):214-7. PubMed ID: 25744270
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine: a paradigm for a sustainable pharmaceutical industry?
Chackalamannil S; Desai MC
Curr Opin Drug Discov Devel; 2009 Jul; 12(4):443-5. PubMed ID: 19562640
[TBL] [Abstract][Full Text] [Related]
15. Time to adapt.
Nature; 2010 Apr; 464(7293):1245-6. PubMed ID: 20428115
[No Abstract] [Full Text] [Related]
16. Hem-onc: a modern parable.
Loeb V
Am J Med; 1989 Sep; 87(3N):4N-6N. PubMed ID: 2486532
[No Abstract] [Full Text] [Related]
17. Clinical cancer informatics: creating pathways for personalized medicine and rapid learning cancer care from the guest editors.
Abernethy AP; Basch E
Cancer J; 2011; 17(4):195-6. PubMed ID: 21799324
[No Abstract] [Full Text] [Related]
18. Circulating tumor cells: personalized medicine in interventional oncology?
Sheth RA; Hesketh R; Deipolyi AR; Oklu R
J Vasc Interv Radiol; 2013 Feb; 24(2):221-8. PubMed ID: 23265726
[TBL] [Abstract][Full Text] [Related]
19. From the evolution of toxin resistance to virtual clinical trials: the role of mathematical models in oncology.
Agur Z
Future Oncol; 2010 Jun; 6(6):917-27. PubMed ID: 20528230
[TBL] [Abstract][Full Text] [Related]
20. ["Hidden hierarchical thinking is not up to date anymore": an interview with Johannes Bruns by Stephanie Hügler].
Bruns J
Dtsch Med Wochenschr; 2011 Apr; 136 Suppl 1():S20-2. PubMed ID: 21452102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
